Lilly Slams Brazil’s Pursuit To Make Off-Patent Mounjaro And Zepbound

 
• By Francesca Bruce
  
Brazil mulls allowing compulsory licenses for Lilly's Mounjaro and Zepbound.
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Patents

More from R&D